Direct Profiling of Extracellular Vesicle Surface Markers in Plasma: A Proof‐of‐Concept Study
Biology of the Cell · 2025
DOI: 10.1111/boc.70047 ↗At a glance
Journal article in Biology of the Cell, 2025. Written by Lee-Ann Clegg and 7 co-authors. Institution: Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark. Major MEDLINE topics: Extracellular Vesicles, Biomarkers. Cited 2 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Novo Nordisk Foundation, Lundbeck Foundation, Danish Neurological Society and Danish Society for Neuroscience.
Abstract (original language)
During the last decade, non‐invasive methods such as liquid biopsy have increasingly replaced invasive techniques for diagnosing and monitoring diseases. Liquid biopsies are easier to obtain, highly sensitive, cost‐effective per sample, and can be used for real‐time monitoring, such as tracking drug response. To uncover molecular and cellular characteristics today, blood, saliva, urine, or cerebrospinal fluid are typically analyzed. In this methodological proof‐of‐concept study, we propose that patient profiling can be facilitated by assessing surface markers on extracellular vesicles (EVs) directly in plasma without prior purification. EV composition reflects the physiological or pathological state of their parent cell, making EVs valuable tools for biomarker discovery and understanding disease mechanisms. Plasma and purified EVs from 30 ischemic stroke patients were analyzed for 17 surface markers using an in‐house protein microarray method (EV Array). The findings indicate that measurements on EVs directly in plasma and on purified EVs show similar patterns in expression of surface markers, supporting the feasibility of omitting purification in EV profiling. This knowledge can provide faster monitoring of various diseases, prevent delays in patient profiling, and optimize patient care.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark.
- Department of Clinical Medicine, Faculty of Medicine, Aalborg University, Aalborg, Denmark.
- Center of Functionally Integrative Neuroscience, Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark.
- Danish Stroke Center, Department of Neurology, Aarhus University Hospital, Aarhus N, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark.
ORCID profiles: Lee-Ann Clegg, Rolf Ankerlund Blauenfeldt, Kim Ryun Drasbek
Funding
- Novo Nordisk Foundation
- Lundbeck Foundation
- Danish Neurological Society and Danish Society for Neuroscience
- Novo Nordisk Fonden
Cite
APA
Clegg, L. A., Jensen, R. B., Bæk, R., Mumm, B. H., Sørensen, M. K., Blauenfeldt, R. A., Drasbek, K. R., & Jørgensen, M. M. (2025). Direct Profiling of Extracellular Vesicle Surface Markers in Plasma: A Proof‐of‐Concept Study. Biology of the Cell. https://doi.org/10.1111/boc.70047
Vancouver
Clegg LA, Jensen RB, Bæk R, Mumm BH, Sørensen MK, Blauenfeldt RA, et al. Direct Profiling of Extracellular Vesicle Surface Markers in Plasma: A Proof‐of‐Concept Study. Biology of the Cell. 2025. doi:10.1111/boc.70047
BibTeX
@article{Clegg2025,
author = {Clegg, Lee-Ann and Jensen, Rebecca Best and Bæk, Rikke and Mumm, Birgitte Hviid and Sørensen, Maria Kjølhede and Blauenfeldt, Rolf Ankerlund and Drasbek, Kim Ryun and Jørgensen, Malene Møller},
title = {Direct Profiling of Extracellular Vesicle Surface Markers in Plasma: A Proof‐of‐Concept Study},
journal = {Biology of the Cell},
year = {2025},
doi = {10.1111/boc.70047}
}
EUVIMED